Document is current
Any future updates will be listed below
-
Authors
Elrewany, Ehab https://orcid.org/0000-0002-8700-0630
Ghazy, Ramy Mohamed https://orcid.org/0000-0001-7611-706X
Shiba, Hoda Ali Ahmed https://orcid.org/0000-0001-8147-3034
Abdel-Rahman, Suzan https://orcid.org/0000-0002-5779-0926
Shabrawy, Abdelhamid El https://orcid.org/0000-0003-4748-0008
alabdo, Nayef kheder
Altayf, Alhasan https://orcid.org/0009-0002-4905-8775
Alshahrani, Fahad Abdullah S. https://orcid.org/0009-0007-5753-1688
Abouelmagd, Moaz Elsayed https://orcid.org/0000-0002-0511-2429
Tarawneh, Haneen https://orcid.org/0009-0001-5980-8069
Al-Muqbel, Rahaf https://orcid.org/0009-0002-1226-2908
Fadl, Noha https://orcid.org/0000-0001-9807-2720
-
Funding
Funding for this research was provided by:
Pfizer Independent Research Grant (Request ID 77570089)
- License Information
-
More Information
Article History
Accepted: 6 May 2025
First Online: 20 May 2025
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. An approval was obtained from the ethics committee of the High Institute of Public Health, Alexandria University, Egypt (IRB number 00013692).
: Informed consent from participants aged 18 years and older, and minor assent from parents/ guardians of participants younger than 18 years were obtained after explanation of the purpose and benefits of the research. For the online survey, the participants and parents/ caregivers should answer a question of voluntary participation to be directed to the survey. Anonymity and confidentiality were guaranteed and maintained.
: There were no conflicts of interest to disclose.
